Ingrid Hofland

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Journal: Breast (Edinburgh, Scotland)
Published: April 18, 2025

Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.

Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy.

Journal: Cancer discovery
Published: November 14, 2024

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Journal: Nature medicine
Published: February 02, 2024

Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).

Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).

Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2023

A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma.

A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 18, 2023

Away from definition and back to the clinic - as response to Kumar et al, 'Evidence is not sufficient to declare the tubal gland conglomerates as salivary.'

Away from definition and back to the clinic - as response to Kumar et al, 'Evidence is not sufficient to declare the tubal gland conglomerates as salivary.'

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 09, 2023

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

Journal: The Journal of clinical investigation
Published: September 29, 2023

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.

Journal: Gynecologic oncology
Published: March 22, 2023

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.

Journal: Insights into imaging
Published: February 25, 2023

Immunohistological profiling confirms salivary gland-like nature of the tubarial glands and suggests closest resemblance to the palatal salivary glands.

Immunohistological profiling confirms salivary gland-like nature of the tubarial glands and suggests closest resemblance to the palatal salivary glands.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 18, 2023

SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response.

SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response.

Journal: Oncoimmunology
Published: December 05, 2022

A pan-cancer analysis of the microbiome in metastatic cancer.

A pan-cancer analysis of the microbiome in metastatic cancer.

Journal: Cell
Published: October 11, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026